Prognostic Factors of Community-acquired Bacteremic Patients with Severe sepsis: A Prospective, Observational Study

Young Kyung Yoon; Min Ja Kim; Dae Won Park; Soon Sun Kwon; Byung Chul Chun; Hee Jin Cheong; Jun Yong Choi; Hee Jung Choi; Young Hwa Choi; Hyo Youl Kim; Joong Sik Eom; Sang Il Kim; Young Goo Song; Kyong Ran Peck; Yang Soo Kim; June Myung Kim; Jang Wook Sohn

doi:10.3947/ic.2012.44.3.168

Journal List > Infect Chemother > v.44(3) > 1035141

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Yoon, Kim, Park, Kwon, Chun, Cheong, Choi, Choi, Choi, Kim, Eom, Kim, Song, Peck, Kim, Kim, Sohn, and Korean Sepsis Working Group: Prognostic Factors of Community-acquired Bacteremic Patients with Severe sepsis: A Prospective, Observational Study

Original Article

Infection & Chemotherapy

Infection & Chemotherapy 2012; 44(3): 168-174.

Published online: 30 June 2012

DOI: https://doi.org/10.3947/ic.2012.44.3.168

Prognostic Factors of Community-acquired Bacteremic Patients with Severe sepsis: A Prospective, Observational Study

Young Kyung Yoon¹, Min Ja Kim¹, Dae Won Park¹, Soon Sun Kwon¹, Byung Chul Chun¹, Hee Jin Cheong¹, Jun Yong Choi², Hee Jung Choi³, Young Hwa Choi⁴, Hyo Youl Kim⁵, Joong Sik Eom⁶, Sang Il Kim⁷, Young Goo Song², Kyong Ran Peck⁸, Yang Soo Kim⁹, June Myung Kim^2,, Jang Wook Sohn^1,; Korean Sepsis Working Group

¹Department of Internal Medicine, Korea University College of Medicine, Seoul, Korea.

²Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

³Department of Internal Medicine, Ewha Womans University School of Medicine, Seoul, Korea.

⁴Department of Internal Medicine, Ajou University School of Medicine, Suwon, Korea.

⁵Department of Internal Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.

⁶Department of Internal Medicine, Hallym University College of Medicine, Chuncheon, Korea.

⁷Department of Internal Medicine, Catholic University College of Medicine, Seoul, Korea.

⁸Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.

⁹Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.

Corresponding author 1: Jang Wook Sohn, MD, PhD. Division of Infectious Diseases, Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Inchon-ro 73, Seongbuk-gu, Seoul 136-705, Korea. Tel: +82-2-920-5018, Fax: +82-2-920-5616, jwsohn@korea.ac.kr; jangwook.sohn@gmail.com

Corresponding author 2: June Myung Kim, MD, PhD. Division of Infectious Diseases, Department of Internal Medicine, Yonsei University College of Medicine, 50 Yonsei-ro Seodaemun-gu Seoul 120-752, Korea. Tel: +82-2-2228-1946, Fax: +82-2-393-6884, jmkim@yuhs.ac

Equal contributor:

*Jang Wook Sohn and June Myung Kim contributed equally to this work.

Received 22 November 2011 Revised 17 April 2012 Accepted 18 April 2012

(open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Background

Characterization of clinical features of bacteremic severe sepsis acquired from the community has been inadequate; therefore, our goal in this study was to identify prognostic factors associated with outcome in patients with community-acquired bacteremic severe sepsis.

Materials and Methods

Adult patients (≥18 years) with community-acquired severe sepsis in whom pathogens were identified from blood cultures were included in the study. Data were collected prospectively from 12 teaching hospitals between May, 2005, and February, 2009. Data included demographic characteristics, co-morbid medical conditions, primary infection sites, sepsis severity, mortality, causative microorganisms, and the appropriateness of initial empirical antibiotic therapy.

Results

During the study period, 1,152 patients were diagnosed with community-acquired severe sepsis and 422 patients were found to harbor pathogens in their blood. Among the 422 patients analyzed, 253 (60.0%) patients went into shock and 121 patients (28.7%) died during hospitalization. Risk factors, including respiratory tract infection (odds ratio [OR], 2.60; 95% confidence interval [CI], 1.11-6.09), number of organ dysfunctions (OR, 1.39; 95% CI, 1.13-1.71), and higher APACHE II scores (OR, 1.08; 95% CI, 1.03-1.13) showed an association with poor survival, whereas Escherichia coli as a pathogen (OR, 0.31; 95% CI, 0.16-0.64) showed an association with lower mortality.

Conclusions

In addition to severity of illness, the primary site of infection and causative microorganisms were also identified as important prognostic factors in patients with community-acquired bacteremic severe sepsis.

Keywords: Prognostic factors, Severe sepsis, Septic shock, Community-acquired infections, Bacteremia

Introduction

Occurrence of severe sepsis, which accounts for 10-30% of intensive care unit (ICU) admissions worldwide, is relatively common [1-4]. While severe sepsis is a deadly medical condition, previous studies involving large observational cohorts have reported an overall rate of mortality ranging between 28.6-56.0% [5, 6]. Many factors can be determinants of poor outcome in patients with severe sepsis; we argue that there are too many to apply in real clinical situations. Typically, the list includes age, severity of a patient's underlying disease, number of dysfunctional organ systems, severity of the illness, hypothermia, thrombocytopenia, lactic acidosis, multiple sources of infection, positive blood cultures, and type of organism [6, 7].

In most studies of severe sepsis, patients were not stratified according to whether the infection was community-acquired vs. hospital acquired or bacteremic vs. non-bacteremic. Previous studies of bacteremic diseases have focused on individual organisms or combined community- and hospital-acquired bacteremia [8, 9]. One study suggested an association of patient outcomes in cases of severe community-acquired bacteremic sepsis with scores for albumin and Acute Physiology and Chronic Health Evaluation II (APACHE II) [10]; however, more data are needed in order to validate these earlier findings.

Epidemiological and prognostic factors associated with severe community-acquired bacteremic sepsis could differ from those of hospital-acquired and/or non-bacteremic cases, and could inform treatment recommendations and aid in establishment of national health policies. Our aim in this study was to describe the clinical and microbiological characteristics of patients with severe community-acquired bacteremic sepsis, and to determine which of these variables are associated with mortality.

Materials and Methods

1. Study design and patients

A prospective, multicenter, observational study was conducted in the medical (n=12) and surgical (n=10) intensive care units (ICUs) of 12 university-affiliated teaching hospitals in the Republic of Korea from April, 2005 to February, 2009. A prospective analysis was conducted using data from adult patients (18 years and older) with severe community-acquired bacteremic sepsis who had been recently admitted to the ICUs of the participating centers. Patient follow-up continued until death or discharge from the hospital. Cases involving recurrence or relapse were excluded. There was no standardized intervention associated with management of sepsis, and physicians followed routine medical practices in treatment of their patients.

Prior to initiation of the study, the protocol was reviewed and approved by the institutional review board from each participating center.

2. Definitions

In this study, for diagnosis of severe sepsis, we used criteria developed by Bernard et al. [11, 12], as well as hepatic dysfunction (serum bilirubin >21 µmol/L), gastrointestinal dysfunction (stress upper gastrointestinal bleeding), and mental change (Glasgow coma scale ≤13). Diagnosis of severe sepsis required evidence of infection and at least two systemic inflammatory response syndrome conditions and at least one organ system dysfunction. Septic shock was diagnosed as sepsis with sustained hypotension lasting at least one hour despite adequate fluid resuscitation or as sepsis requiring vasopressors for maintenance of adequate systolic blood pressure [11]. Severe community-acquired sepsis was defined as the presence of severe sepsis upon admission or sepsis that developed within 24 hours of admission. According to the previously mentioned criteria, cases involving nosocomial infection were excluded [13]. Infections that became evident <48 hours after discharge from the hospital were deemed nosocomial [13]. Determination of the primary site of infection was based on the organs affected and was classified as one of the following: lower respiratory tract, intra-abdominal, genitourinary tract, skin and soft tissue, central nervous system, or primary bloodstream infection, which was defined as a positive blood culture without focus.

Isolation of one or more viable microorganisms from blood cultures resulted in diagnosis of bacteremia. Isolation of common skin-dwelling organisms, such as coagulase-negative Staphylococcus species and Bacillus species, from two or more blood cultures from a suspected patient was considered significant. The final diagnosis was made by infectious disease specialists.

Initial empirical antibiotic therapy was defined as appropriate when antibiotics were started intravenously with optimal dosing and intervals within 24 hours after recognition of severe sepsis or septic shock, and the infecting microorganism was subsequently found to be susceptible in vitro to the antibiotics administered.

3. Data collection

For the first 24 hours following admission, data for each patient were collected using the standardized web-based case report form via the website of the Korean Society of Infectious Diseases. Data included demographic characteristics, co-morbid medical conditions, as determined by Charlson's comorbidity index [14], factors predisposing to infection, primary site of infection, APACHE II scores [15], and diagnosis of severe sepsis, septic shock, and organ dysfunction. Sepsis-related Organ Failure Assessment (SOFA) scores [16], microorganism isolates, and hospital mortality data were also collected at admission.

4. Statistical analyses

The Chi-square test or Fisher's exact test was used for comparison of categorical variables. Continuous variables were expressed as means±standard deviations, and t-tests were performed for comparison of means. For determination of independent factors sociated with mortality, variables that showed a significant association with in-hospital mortality in univariate analysis were further analyzed using multivariate logistic regression analysis. Statistical significance was defined as a two-tailed P value<0.05.

SPSS version 13.0 (SPSS Inc., Chicago, IL, USA) was used in performance of statistical analyses.

Results

1. Patient characteristics

During the study period, data from 1,357 cases were collected and 1,152 patients were diagnosed with severe community-acquired sepsis. Among them, 422 patients documented as having severe community-acquired bacteremic sepsis were subsequently included in this study (Fig. 1). While occurrence of all-cause in-hospital mortality was observed in 121 patients (28.7%), 7-day and 28-day mortality rates were 14.9% (63 of 422) and 24.6% (104 of 422), respectively. The mean hospital stay was 3.96±93.08 days (range 0-939, median 16 days).

Sex distribution was nearly equal, and the mean age (years) of patients was 64.6±14.3 (range 18-97, median 66). Underlying disease was observed in 300 patients (71.1%), with a mean Charlson score index of 1.6±1.3 (range 0-9). Detailed comorbidity and severity parameters for the enrolled patients are shown in Table 1. Initially detected major clinical manifestations were as follows: hypotension (58.3%), hematologic dysfunction (58.3%), renal dysfunction (41.2%), liver dysfunction (37.4%), mental change (36.0%), respiratory failure (32.5%), metabolic acidosis (29.6%), cardiac dysfunction (13.5%), and gastrointestinal bleeding (3.3%). The mean number of organ dysfunctions was 2.7±1.6 (range, 0-7).

2. Primary site of infection

The most common primary site of infection was intra-abdominal (34.4%), followed by the urinary tract (28.4%), primary bloodstream (11.1%), and respiratory tract (10.9%). In-hospital mortality due to respiratory tract, primary bloodstream, skin and soft tissue, intra-abdominal, cardiovascular, and urinary tract infections was 54.3%, 46.8%, 39.4%, 29.0%, 13.3%, and 9.2%, respectively (Table 2).

3. Microbiology

Compared with Gram-positive bacteria (25.1%), a greater percentage of pathogens were Gram-negative bacteria (72.0%). Polymicrobial infections and anaerobic infections accounted for 2.8% and 0.2% of infections, respectively. Among Gram-negative microorganisms, the most common pathogen was Escherichia coli (37.7%), followed by Klebsiella pneumoniae (22.0%). The most common Gram-positive pathogen was Staphylococcus aureus (11.8%), followed by Streptococcus pneumoniae (10.2%). The top three common causative microorganisms according to primary site of infection are shown in Table 3.

4. Independent risk factors for in-hospital mortality

In univariate analysis of the demographic and clinical characteristics of patients and their severity of illness, the APACHE II score and the number of organ dysfunctions differed significantly between survivors and non-survivors (Table 1). Only a small proportion of patients (32/422, 7.6%) received inappropriate antibiotic treatment; therefore, inadequate initial antimicrobial treatment might not contribute to in-hospital mortality. Mortality rate is higher for patients with sepsis associated with respiratory tract infection, primary bloodstream infection, or caused by Pseudomonas aeruginosa or S. aureus, while a lower mortality rate was observed for patients with urinary tract infections and E. coli as a pathogen (Tables 2 and 4).

Multivariate logistic regression analysis was performed for further analysis of significant parameters found by univariate analyses. Respiratory tract infection (odds ratio [OR], 2.60; 95% confidence interval [CI], 1.11-6.09), number of organ system dysfunctions (OR, 1.39; 95% CI, 1.13-1.71), and APACHE II score (OR, 1.08; 95% CI, 1.03-1.13) showed an association with a greater risk of death, whereas E. coli bacteremia (OR, 0.31; 95% CI, 0.16-0.64) was associated with a lower risk. Independent risk factors associated with 7-day and 28-day mortality in multivariate logistic regression analysis are shown in Table 5.

Discussion

In the present study, all-cause in-hospital mortality was 28.7% (121 of 422 patients). Patients who presented with shock showed a slightly lower rate of mortality (26.9%) than patients without shock. As reported in previous studies, mortality resulting from severe sepsis ranged from 28.6-56.0%, and mortality rate for patients with septic shock were higher (40-70%) than those of patients with sepsis alone (25-30%) [3, 5, 6, 17, 18]. In a study of patients with severe community-acquired bacteremic sepsis, Artero et al. reported an all-cause in-hospital mortality rate of 34.4% [10], higher than the mortality rate recorded in this study. The modest result for general mortality and the unexpected result for lower mortality in patients with shock may be due to inclusion of cases with different disease severities, as reflected by APACHE II scores, compared to the previous study (19.4 in our study vs. 22.0 in the other study), as well as a disparity in the most common site of primary infection (urinary tract infection in our study vs. respiratory tract infection in the previous study) [10].

Our finding that E. coli was the most common isolate from patients with severe community-acquired bacteremic sepsis (159 of 422, 37.7%) is in agreement with results reported by Diekema et al. [19]. However, other studies have reported a general, worldwide increase in occurrence of Gram-positive infections, such as S. aureus infections [10, 20, 21]. Differences in proportions of causative organisms may be the result of differences in the primary focus of infection. Mylotte et al. [20] reported pneumonia as the most common site of infection. However, in our study, the most common primary site of infection was intra-abdominal (34.4%), followed by the urinary tract (28.4%), primary bloodstream (11.1%), and respiratory tract (10.9%). Consistent with the findings of other studies, we found that lower respiratory tract infection, severity of illness upon admission, and the presence of multiple organ dysfunctions were the major factors associated with a poor prognosis in Korean patients with severe community-acquired bacteremic sepsis [8, 10, 20, 22, 23]. Infection with E. coli showed an association with lower mortality, which is also consistent with results reported by another study [24]. No significant association was observed between inadequate empirical antimicrobial treatment and higher mortality. However, administration of inadequate empirical antimicrobial treatment to critically ill patients with bloodstream infections has been reported as a key prognostic factor leading to a poor outcome [25, 26]. Discordance between results of our study and those of previous studies might be attributed to the fact that, in our study, only a few patients (7.6%) received inappropriate initial antibiotic treatment. The low rate of inadequate antimicrobial treatment may be due to the nature of the involved hospitals; all patients were recruited from university-affiliated teaching hospitals with specialists in infectious disease on staff.

This study had several limitations. First, it was performed within the ICUs of 12 university-affiliated teaching hospitals having a low prevalence of inadequate antimicrobial treatment. Therefore, it may be that the results of this study cannot be generalized to other hospitals. Second, it was an observational study, and, even though there was no standardized intervention for management of sepsis at different hospitals, the study center was not included as a separate variable. Nevertheless, specialists in infectious disease, especially those trained to care for critically ill patients, participated in management of these patients. Third, our patient cohort did not include a consecutive series of ICU patients with community-acquired infections, which may have led to selection bias for more severe infections, with a higher likelihood of mortality. However, there is no reason to believe that this would have changed the predisposing factors associated with mortality.

In conclusion, we found that disease severity, based on both the number of organ system dysfunctions and APACHE II score, in addition to microbiological factors and primary site of bacteremia, are in-hospital prognostic determinants of outcome in patients with severe community-acquired bacteremic sepsis in Korea.

Figures and Tables

Figure 1

Process used for selection of eligible patients with bacteremia from among those with severe community-acquired sepsis.

Table 1

Demographic and Clinical Characteristics and Mortality in Community-acquired Bacteremic Patients with Severe Sepsis

APACHE II, Acute Physiology and Chronic Health Evaluation II score; SOFA, Sepsis-related Organ Failure Assessment; SD, standard deviation

^aP-values were obtained by using the Chi-square test, unless otherwise indicated.

^bFisher's exact test was used.

Table 2

Primary Site of Infection and Mortality in Community-acquired Bacteremic Patients with Severe Sepsis

^aP-values were obtained using the Chi-square test, unless otherwise indicated.

^bAbdominal infections include gastrointestinal tract infection (n=42), liver abscess (n=37), and other intra-abdominal infection (n=66).

^cFisher's exact test was used.

Table 3

The three most Common Microorganisms According to Primary Sites of Infection and Mortality in Community-acquired Bacteremic Patients with Severe Sepsis

^aP-values were obtained using the Chi-square test, unless otherwise indicated.

^bFisher's exact test was used.

Table 4

Causative Microorganisms and Mortality in Community-acquired Bacteremic Patients with Severe Sepsis

^aP-values were obtained using the Chi-square test, unless otherwise indicated.

^bFisher's exact test was used.

Table 5

Risk Factors Associated with Mortality Based on Multivariate Logistic Regression Analysis of the Characteristics of Community-acquired Bacteremic Patients with Severe Sepsis

OR, odds ratio; CI, confidence interval; APACHE II, Acute Physiology and Chronic Health Evaluation II score

^aIn multivariate logistic regression analysis, age, sex, number of organ system dysfunctions, APACHE II score, primary bloodstream infection, respiratory tract infection, Pseudomonas aeruginosa bacteremia, Escherichia coli bacteremia, Staphylococcus aureus bacteremia, and red blood cell transfusion were included.

^bIn multivariate logistic regression analysis, age, sex, number of organ system dysfunctions, APACHE II score, primary bloodstream infection, respiratory tract infection, and E. coli bacteremia were included.

^cIn multivariate logistic regression analysis, age, sex, number of organ system dysfunctions, APACHE II score, primary bloodstream infection, respiratory tract infection, E. coli bacteremia, and red blood cell transfusion were included.

Acknowledgements

This study was supported by a research grant from the Korean Society of Infectious Diseases and by a grant from the National Research Foundation of Korea (NRF) funded by the Korean government (MEST) (No. K20902001448-10E0100-03010).

Notes

We have no competing financial interests to declare.

References

1. van Gestel A, Bakker J, Veraart CP, van Hout BA. Prevalence and incidence of severe sepsis in Dutch intensive care units. Crit Care. 2004. 8:R153–R162.

2. Burchardi H, Schneider H. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy. Pharmacoeconomics. 2004. 22:793–813.

3. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, Moreno R, Carlet J, Le Gall JR, Payen D. Sepsis Occurrence in Acutely Ill Patients Investigators. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006. 34:344–353.

4. Annane D, Aegerter P, Jars-Guincestre MC, Guidet B. CUB-Réa Network. Current epidemiology of septic shock: the CUB-Réa Network. Am J Respir Crit Care Med. 2003. 168:165–172.

5. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001. 29:1303–1310.

6. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, Mercier JC, Offenstadt G, Régnier B. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. A multicenter prospective study in intensive care units. French ICU Group for Severe Sepsis. JAMA. 1995. 274:968–974.

7. Annane D, Sébille V, Troché G, Raphaël JC, Gajdos P, Bellissant E. A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotropin. JAMA. 2000. 283:1038–1045.

8. Laupland KB, Davies HD, Church DL, Louie TJ, Dool JS, Zygun DA, Doig CJ. Bloodstream infection-associated sepsis and septic shock in critically ill adults: a population-based study. Infection. 2004. 32:59–64.

9. Raymond NJ, Blackmore TK, Humble MW, Jones MR. Bloodstream infections in a secondary and tertiary care hospital setting. Intern Med J. 2006. 36:765–772.

10. Artero A, Zaragoza R, Camarena JJ, Sancho S, González R, Nogueira JM. Prognostic factors of mortality in patients with community-acquired bloodstream infection with severe sepsis and septic shock. J Crit Care. 2010. 25:276–281.

11. Longo DL, Fauci AS, Kasper DL, Hauser SL, Jameson JL, Joseph L. Harrison's principles of Internal Medicine. 2011. 18th ed. New York: McGraw-Hill.

12. Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ Jr. Recombinant human protein C Worldwide Evaluation in Severe Sepsis (PROWESS) study group. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med. 2001. 344:699–709.

13. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988. 16:128–140.

14. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994. 47:1245–1251.

15. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985. 13:818–829.

16. Ferreira FL, Bota DP, Bross A, Mélot C, Vincent JL. Serial evaluation of the SOFA score to predict outcome in critically ill patients. JAMA. 2001. 286:1754–1758.

17. Martin CM, Priestap F, Fisher H, Fowler RA, Heyland DK, Keenan SP, Longo CJ, Morrison T, Bentley D, Antman N. STAR Registry Investigators. A prospective, observational registry of patients with severe sepsis: the Canadian Sepsis Treatment and Response Registry. Crit Care Med. 2009. 37:81–88.

18. Harrison DA, Welch CA, Eddleston JM. The epidemiology of severe sepsis in England, Wales and Northern Ireland, 1996 to 2004: secondary analysis of a high quality clinical database, the ICNARC Case Mix Programme Database. Crit Care. 2006. 10:R42.

19. Diekema DJ, Beekmann SE, Chapin KC, Morel KA, Munson E, Doern GV. Epidemiology and outcome of nosocomial and community-onset bloodstream infection. J Clin Microbiol. 2003. 41:3655–3660.

20. Mylotte JM, Kahler L, McCann C. Community-acquired bacteremia at a teaching versus a nonteaching hospital: impact of acute severity of illness on 30-day mortality. Am J Infect Control. 2001. 29:13–19.

21. Laupland KB, Gregson DB, Zygun DA, Doig CJ, Mortis G, Church DL. Severe bloodstream infections: a population-based assessment. Crit Care Med. 2004. 32:992–997.

22. Blanco J, Muriel-Bombín A, Sagredo V, Taboada F, Gandía F, Tamayo L, Collado J, García-Labattut A, Carriedo D, Valledor M, De Frutos M, López MJ, Caballero A, Guerra J, Alvarez B, Mayo A, Villar J. Grupo de Estudios y Análisis en Cuidados Intensivos. Incidence, organ dysfunction and mortality in severe sepsis: a Spanish multicentre study. Crit Care. 2008. 12:R158.

23. Guidet B, Aegerter P, Gauzit R, Meshaka P, Dreyfuss D. CUB-Réa Study Group. Incidence and impact of organ dysfunctions associated with sepsis. Chest. 2005. 127:942–951.

24. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005. 49:760–766.

25. Vallés J, Rello J, Ochagavía A, Garnacho J, Alcalá MA. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest. 2003. 123:1615–1624.

26. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000. 118:146–155.

TOOLS

Similar articles